80 related articles for article (PubMed ID: 32141531)
1. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
3. miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.
Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ
Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903
[TBL] [Abstract][Full Text] [Related]
4. miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1.
Jiang B; Kang X; Zhao G; Lu J; Wang Z
Comput Math Methods Med; 2021; 2021():2895893. PubMed ID: 34950224
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Ubiquitin-Specific Protease 22 Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Osteosarcoma Cells.
Zhang D; Jiang F; Wang X; Li G
Oncol Res; 2017 May; 25(5):743-751. PubMed ID: 27983930
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p.
Wang Z; Wei Y; Zhu H; Yu L; Zhu J; Han Q; Liu Z; Huang J; Zhu Y; Fan G; Tang Q; Qian J; Chen X; Zhou G
BMC Cancer; 2022 Jul; 22(1):728. PubMed ID: 35787258
[TBL] [Abstract][Full Text] [Related]
7.
Yang B; Wang B; Wang G; Cao W; Wang Q; Pu H; An W
Anticancer Agents Med Chem; 2023; 23(13):1577-1586. PubMed ID: 37139674
[TBL] [Abstract][Full Text] [Related]
8. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract][Full Text] [Related]
9. miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1.
Han B; Huang J; Yang Z; Zhang J; Wang X; Xu N; Meng H; Wu J; Huang Q; Yang X; Shen R; Sun C
Onco Targets Ther; 2019; 12():10975-10987. PubMed ID: 31853185
[TBL] [Abstract][Full Text] [Related]
10. Exosome microRNA-22 inhibiting proliferation, migration and invasion through regulating Twist1/CADM1 axis in osteosarcoma.
Ruan Q; Wang C; Wu Y; Zhu Q
Sci Rep; 2024 Jan; 14(1):761. PubMed ID: 38191892
[TBL] [Abstract][Full Text] [Related]
11. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter.
Gan L; Xu M; Hua R; Tan C; Zhang J; Gong Y; Wu Z; Weng W; Sheng W; Guo W
J Hematol Oncol; 2018 Jan; 11(1):9. PubMed ID: 29335012
[TBL] [Abstract][Full Text] [Related]
12. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling.
Jiang Y; Gao Y; Li X; He F; Liu Y; Wang R
J Orthop Surg Res; 2023 Dec; 18(1):985. PubMed ID: 38129870
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of PIM kinases in osteosarcoma.
Mou S; Wang G; Ding D; Yu D; Pei Y; Teng S; Fu Q
Int J Oncol; 2016 Nov; 49(5):2116-2126. PubMed ID: 27826617
[TBL] [Abstract][Full Text] [Related]
14. Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion.
Raimondi L; Gallo A; Cuscino N; De Luca A; Costa V; Carina V; Bellavia D; Bulati M; Alessandro R; Fini M; Conaldi PG; Giavaresi G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054891
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma.
Yang L; Xie F; Li S
Oncol Res; 2017 Aug; 25(7):1089-1095. PubMed ID: 27983923
[TBL] [Abstract][Full Text] [Related]
16. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.
Li A; Wang S; Nie J; Xiao S; Xie X; Zhang Y; Tong W; Yao G; Liu N; Dan F; Shu Z; Liu J; Liu Z; Yang F
Cell Death Dis; 2024 Mar; 15(3):235. PubMed ID: 38531846
[TBL] [Abstract][Full Text] [Related]
17. [miR-449a/b negatively regulates E2F1 to suppress proliferation of gastric cancer cells].
Lin A; Bu W; Wang P; Gao J; Yang J; Ding F; Li T
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):13-19. PubMed ID: 32376557
[TBL] [Abstract][Full Text] [Related]
18. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Long Non-Coding RNA LINC01106 Suppresses the Proliferation, Migration and Invasion of Endometrial Cancer Cells Through Regulating the miR-449a/MET Axis.
Gao X; Yu L; Zhang J; Xue P
Onco Targets Ther; 2020; 13():9643-9655. PubMed ID: 33061446
[TBL] [Abstract][Full Text] [Related]
20. Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells.
Li CY; Chen HC; Liao CY; Hsu FT; Hung KC; Liu KC; Chen JC; Ku MC
Anticancer Res; 2024 Jan; 44(1):85-92. PubMed ID: 38160012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
